Dendritic cells (DC) are potent antigen-presenting cells with the unique ca
pacity to initiate primary immune responses. As a result, DC are currently
used in clinical studies to induce immunity against infectious disease and
malignant cells. However, multiple DC subsets exist and it has been suggest
ed that the type of DC may affect the immune response induced. The vast maj
ority of DC used in experimental mouse tumor models is derived from bone ma
rrow progenitors. In contrast, most in vitro as well as in vivo human studi
es involve the use of DC generated from adherent peripheral blood-derived m
onocytes in the presence of GM-CSF and IL-4. In the current report, we desc
ribe for the first time the generation and characterization of mouse monocy
te-derived DC (MODC). The results indicate that mouse MODC display similar
morphology, phenotype and immunostimulatory activity as compared to bone ma
rrow-derived DC. Both DC subsets were able to efficiently take up and subse
quently cross-present protein antigen to cytotoxic T cells. Moreover, we de
monstrate that vaccination with peptide-loaded MODC mediates induction of t
umor-reactive immunity in vivo. The isolation and characterization of mouse
MODC will provide a valuable research tool to investigate fundamental aspe
cts of DC biology and which DC subsets are most suitable to induce anti-tum
or immunity.